Promotion of CHIP-Mediated p53 Degradation Protects the Heart From Ischemic Injury
Autor: | Koji Iwanaga, Toshio Nagai, Hiroshi Akazawa, Issei Komuro, Sho Okada, Tohru Minamino, Tomokazu Sumida, Seitaro Nomura, Ichiro Shiojima, Naruhiko Sahara, Atsuhiko T. Naito, Akihiko Takashima, Tatsuya Mizoroki, Mei-Lan Liu |
---|---|
Rok vydání: | 2010 |
Předmět: |
Male
Physiology Myocardial Infarction Apoptosis Endogeny law.invention Mice Transcription (biology) law Chlorocebus aethiops Benzoquinones Myocytes Cardiac Myocardial infarction Promoter Regions Genetic Mice Knockout Ventricular Remodeling Cell Hypoxia COS Cells Cardiology RNA Interference Cardiology and Cardiovascular Medicine Transcriptional Activation Proteasome Endopeptidase Complex medicine.medical_specialty Lactams Macrocyclic Ubiquitin-Protein Ligases Molecular Sequence Data In vivo Internal medicine medicine Animals Humans HSP90 Heat-Shock Proteins Rats Wistar Base Sequence business.industry Ubiquitination Antagonist Genetic Therapy Hypoxia-Inducible Factor 1 alpha Subunit medicine.disease Rats Mice Inbred C57BL Disease Models Animal Animals Newborn Heart failure Mutation Cancer research Suppressor Tumor Suppressor Protein p53 business Protein Processing Post-Translational |
Zdroj: | Circulation Research. 106:1692-1702 |
ISSN: | 1524-4571 0009-7330 |
Popis: | Rationale : The number of patients with coronary heart disease, including myocardial infarction, is increasing and novel therapeutic strategy is awaited. Tumor suppressor protein p53 accumulates in the myocardium after myocardial infarction, causes apoptosis of cardiomyocytes, and plays an important role in the progression into heart failure. Objectives : We investigated the molecular mechanisms of p53 accumulation in the heart after myocardial infarction and tested whether anti-p53 approach would be effective against myocardial infarction. Methods and Results : Through expression screening, we found that CHIP (carboxyl terminus of Hsp70-interacting protein) is an endogenous p53 antagonist in the heart. CHIP suppressed p53 level by ubiquitinating and inducing proteasomal degradation. CHIP transcription was downregulated after hypoxic stress and restoration of CHIP protein level prevented p53 accumulation after hypoxic stress. CHIP overexpression in vivo prevented p53 accumulation and cardiomyocyte apoptosis after myocardial infarction. Promotion of CHIP function by heat shock protein (Hsp)90 inhibitor, 17-allylamino-17-demethoxy geldanamycin (17-AAG), also prevented p53 accumulation and cardiomyocyte apoptosis both in vitro and in vivo. CHIP-mediated p53 degradation was at least one of the cardioprotective effects of 17-AAG. Conclusions : We found that downregulation of CHIP level by hypoxia was responsible for p53 accumulation in the heart after myocardial infarction. Decreasing the amount of p53 prevented myocardial apoptosis and ameliorated ventricular remodeling after myocardial infarction. We conclude that anti-p53 approach would be effective to treat myocardial infarction. |
Databáze: | OpenAIRE |
Externí odkaz: |